ECSP055630A - PROCEDIMIENTOS MICROBIOLÓGICOS PARA PREPARAR 11a-HIDROXIESTEROIDES 7a-SUSTITUIDOS - Google Patents

PROCEDIMIENTOS MICROBIOLÓGICOS PARA PREPARAR 11a-HIDROXIESTEROIDES 7a-SUSTITUIDOS

Info

Publication number
ECSP055630A
ECSP055630A EC2005005630A ECSP055630A ECSP055630A EC SP055630 A ECSP055630 A EC SP055630A EC 2005005630 A EC2005005630 A EC 2005005630A EC SP055630 A ECSP055630 A EC SP055630A EC SP055630 A ECSP055630 A EC SP055630A
Authority
EC
Ecuador
Prior art keywords
hydroxysteroids
prepare
replaced
microbiological procedures
compounds
Prior art date
Application number
EC2005005630A
Other languages
English (en)
Inventor
Peter Muhn
Reinhard Nubbemeyer
Rolf Bohlmann
Ludwig Zorn
Norbert Gallus
Hermann Kuenzer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP055630A publication Critical patent/ECSP055630A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe una novedosa síntesis para preparar productos precursores destinados a la producción de compuestos de la fórmula general (8,10,12). Durante dicha síntesis se producen los compuestos de la fórmula general (4,B) en una reacción microbiológica. Los significados de los radicales R7, R10, R11, R13, R17 y R17'y del grupo U-V-W-X-Y-Z se indican en las reivindicaciones.
EC2005005630A 2002-07-24 2005-02-24 PROCEDIMIENTOS MICROBIOLÓGICOS PARA PREPARAR 11a-HIDROXIESTEROIDES 7a-SUSTITUIDOS ECSP055630A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
ECSP055630A true ECSP055630A (es) 2005-04-18

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005630A ECSP055630A (es) 2002-07-24 2005-02-24 PROCEDIMIENTOS MICROBIOLÓGICOS PARA PREPARAR 11a-HIDROXIESTEROIDES 7a-SUSTITUIDOS

Country Status (20)

Country Link
EP (1) EP1523568A2 (es)
JP (1) JP4417838B2 (es)
KR (1) KR101041328B1 (es)
CN (1) CN100339486C (es)
BR (1) BR0313210A (es)
CA (1) CA2492079C (es)
CO (1) CO5690563A2 (es)
CR (1) CR7672A (es)
EA (2) EA008147B1 (es)
EC (1) ECSP055630A (es)
HK (1) HK1081999A1 (es)
HR (1) HRP20050172A2 (es)
IL (1) IL166358A0 (es)
MX (1) MXPA05001024A (es)
NO (1) NO20050980L (es)
NZ (2) NZ537871A (es)
PH (1) PH12005500143B1 (es)
PL (1) PL373808A1 (es)
RS (1) RS51855B (es)
WO (1) WO2004011663A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200804405A (en) * 2005-10-27 2008-01-16 Taiho Pharmaceutical Co Ltd Process for production of steroid compound
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75841C (es) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167381A3 (en) * 1995-12-11 2004-09-29 G.D. Searle & Co. Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein
ATE215606T1 (de) * 1995-12-12 2002-04-15 Akzo Nobel Nv Mikrobielle 11alpha-hydroxylierung von steroiden
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
EP1267885B8 (en) 2000-02-15 2007-06-20 Bayer Schering Pharma Aktiengesellschaft Male contraceptive formulation comprising norethisterone and testosterone undecanoate
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
JP2006502997A (ja) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト アンドロゲン１１β‐ハロゲンステロイドおよびゲスタゲンを含有する組成物ならびにこの組成物に基づく男性用避妊薬

Also Published As

Publication number Publication date
EA200500224A1 (ru) 2005-08-25
MX260952B (es) 2008-10-01
JP4417838B2 (ja) 2010-02-17
EA200601030A1 (ru) 2006-10-27
KR20050026507A (ko) 2005-03-15
JP2006503813A (ja) 2006-02-02
CO5690563A2 (es) 2006-10-31
NZ537871A (en) 2006-10-27
CA2492079A1 (en) 2004-02-05
WO2004011663A3 (de) 2004-07-15
CN100339486C (zh) 2007-09-26
KR101041328B1 (ko) 2011-06-14
EA010572B1 (ru) 2008-10-30
PH12005500143B1 (en) 2011-03-25
HRP20050172A2 (en) 2005-04-30
PL373808A1 (en) 2005-09-19
CA2492079C (en) 2012-01-10
AU2003281677A1 (en) 2004-02-16
RS20050045A (en) 2007-06-04
IL166358A0 (en) 2006-01-16
HK1081999A1 (en) 2006-05-26
CR7672A (es) 2006-05-29
EA008147B1 (ru) 2007-04-27
MXPA05001024A (es) 2005-05-16
CN1671858A (zh) 2005-09-21
EP1523568A2 (de) 2005-04-20
RS51855B (sr) 2012-02-29
NZ549529A (en) 2008-04-30
NO20050980L (no) 2005-02-23
WO2004011663A9 (de) 2004-05-06
BR0313210A (pt) 2005-06-28
WO2004011663A2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
MY139235A (en) One step process for the preparation of anticonvulsant derivatives
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
CY1107080T1 (el) Υποκατεστημενες ινδολο-βασεις του mannich
HUP0300567A2 (hu) Eljárás új piperazinszármazékok elżállítására
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
HRP20010514B1 (en) Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
CY1107974T1 (el) Παραγωγα κινολινης και κιναζολινης εχοντα συναφεια προς τους υποδοχεις τυπου 5ht1
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200401528A1 (ru) Производные диарилсульфидов, способ их получения и промежуточные соединения
ECSP055630A (es) PROCEDIMIENTOS MICROBIOLÓGICOS PARA PREPARAR 11a-HIDROXIESTEROIDES 7a-SUSTITUIDOS
ES2193946T3 (es) Procedimientos para la preparacion de alcosiaminas a partir de nitroxidos.
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
ATE339427T1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
NO20064352L (no) Fremgangsmate for fremstilling av pyrrolidinoksimer
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
ECSP003761A (es) Compuestos heterociclicos sililados
PE20020829A1 (es) Derivados del biciclo[3.1.0]hexano